Skip to content

Advanced Wireless, Wearable Sensors for Continuous Hemodynamic Monitoring

Advanced Wireless, Wearable Sensors for Continuous Hemodynamic Monitoring

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04362553
Enrollment
42
Registered
2020-04-27
Start date
2020-06-01
Completion date
2022-09-05
Last updated
2022-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congestive Heart Failure

Brief summary

Percent agreement of vital signs monitoring between the experimental sensor and standard of care monitoring

Interventions

vital signs monitoring during standard of care procedures; TTE, swan-ganz catheterization

Sponsors

Northwestern University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years

Inclusion criteria

1. Patient's aged 18-65 2. Patient's scheduled to undergo a Trans-thoracic Echocardiogram (TTE) in an outpatient cardiology clinic or admitted to the Cardiac Care Unit with a swan ganz catheter in place for continuous invasive hemodynamic monitoring

Exclusion criteria

1. Patient's with fragile skin or skin conditions that would prevent them from having a sensor placed 2. Patients undergoing exercise or drug induced cardiac stress test 3. Patients with a visible wound at site of sensor placement 3.4. Patients with structural or functional limitations to peripheral blood flow (known upper extremity peripheral arterial disease, use of vasopressors etc.).

Design outcomes

Primary

MeasureTime frameDescription
Percent agreement with pilot sensor and current standard of vital signs monitoring2 yearsPercent agreement with pilot sensor and current standard of vital signs monitoring

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026